Intestinal disease characterized by inflammation located in all parts of digestive tract.
1Steroids are still widely used in the treatment of inflammatory bowel diseases.
2Probiotics have been shown to exert beneficial effects on inflammatory bowel diseases.
3Intestinal dysbiosis is linked to numerous gastrointestinal disorders, including inflammatory bowel diseases.
4Actually, probiotic blends and anti-inflammatory drugs represent a weapon against inflammatory bowel diseases.
5Despite the development of novel therapies, inflammatory bowel diseases remain an innovative treatment challenge.
6Such persistent modifications could predispose young adults to inflammatory bowel diseases (IBD).
7Anemia is a common complication of inflammatory bowel diseases.
8The etiology of inflammatory bowel diseases remains largely unknown.
9The etiology of inflammatory bowel diseases is only partially explained by the current genetic risk map.
10Background: Gut bacteria trigger colitis in animal models and are suspected to aggravate inflammatory bowel diseases.
11Further studies are needed to determine how thalidomide therapy affects long-term progression of inflammatory bowel diseases.
12Hematopoietic stem cell transplantation has emerged as a new potential therapeutic tool for inflammatory bowel diseases.
13More than seventy years after their initial characterisation, the aetiology of inflammatory bowel diseases remains elusive.
14Interestingly, the pattern of IgG anti-endothelial cell subclass observed in the two inflammatory bowel diseases differs.
15Purpose of review: To consider new data and directions coming from experimental models of inflammatory bowel diseases.
16Patients with a long-term history of inflammatory bowel diseases show an increased risk of developing colorectal cancers.
Translations for inflammatory bowel diseases